AstraZeneca PLC Holdings Report: Capital Group Boosts Voting Rights to 5.01%
Here are the key details extracted from the financial report (Form 6-K) regarding holdings in AstraZeneca PLC:
General Information
- Form Type: 6-K
- Issuer: AstraZeneca PLC
- Commission File Number: 001-11960
- Document Date: 26 August 2025
- Reporting Period: August 2025
Holdings Notification
- ISIN: GB0009895292
- Type of Issuer: UK
- Reason for Notification: Acquisition or disposal of voting rights
Shareholder Details
- Name of Shareholder: The Capital Group Companies, Inc.
- City of Registered Office: Los Angeles
- Country of Registered Office: USA
Voting Rights Details
- Date Threshold Crossed: 22 August 2025
- Date Issuer Notified: 25 August 2025
- Voting Rights Held:
- Total Voting Rights: 77,684,561
- Percentage of Voting Rights: 5.009701%
- Previous Notification Percentage: 4.997854%
Breakdown of Holdings
- Voting Rights Attached to Shares:
- Common Stock (ISIN: GB0009895292): 62,998,778 shares (4.062648%)
- Depository Receipts (ISIN: US0463531089): 14,685,783 shares (0.947053%)
- Total Voting Rights from Shares: 77,684,561 (5.009701%)
- Financial Instruments:
- Voting Rights through Financial Instruments:
- No voting rights reported from financial instruments.
Additional Information
- The Capital Group Companies, Inc. is the parent company of several investment management firms, and the shares reported are held in accounts under discretionary investment management.
Signatory
- Signed by: Matthew Bowden, Company Secretary, AstraZeneca PLC
This report indicates a modest increase in the percentage of voting rights held by The Capital Group Companies, Inc. in AstraZeneca PLC, suggesting potential strategic positioning or investment interest in the company.
